AI Keynote for Healthcare & Life Sciences Leaders
From hospitals to biotech pioneers, Alex Goryachev equips leaders with tailored keynotes and workshops that transform care, research, and patient outcomes.
FREQUENTLY FEATURED IN:
ALEX, BY THE NUMBERS
Healthcare is being told AI will transform everything — while clinicians drown in documentation, regulators sharpen their pencils, and patients wonder who's actually making decisions about their care. The tension isn't whether to use AI. It's how to move fast enough to matter without breaking the trust the entire system runs on.
Why healthcare & life sciences is different
No other industry combines this level of regulatory scrutiny with this level of human stakes. A hallucinating chatbot is an embarrassment in most sectors; in a clinical context it's a safety event. Leaders here evaluate AI through layers most industries never touch — patient privacy, clinical validation, liability, payer dynamics, and the reality that "move fast and break things" is disqualifying when the things are people.
At the same time, the pressure to adopt is enormous and legitimate. Workforce shortages are structural. Administrative burden is burning out the clinicians you can't afford to lose. Drug discovery and trial design are being reshaped by AI whether your organization participates or not. Sitting out isn't neutral — it's a decision to let costs, burnout, and competitors compound.
The organizations getting this right aren't the ones with the biggest AI budgets. They're the ones that pick problems worth solving — documentation, scheduling, prior authorization, trial recruitment — and pair every deployment with governance clinicians actually trust.
What this keynote delivers
- A clear-eyed map of where AI delivers real value in healthcare operations and life sciences today — and where claims outrun evidence
- How to prioritize AI use cases when everything feels urgent: a filter for clinical risk, workforce impact, and time-to-value
- Governance principles for regulated environments that enable adoption rather than becoming a second compliance department
- What agentic AI means when the action touches a patient record, a claim, or a trial protocol
- How to engage clinicians and scientists as co-owners of AI adoption
Why Alex for healthcare & life sciences
Alex has presented to leading organizations including Pfizer, and his focus on AI governance speaks to what regulated industries need most: adoption with accountability. He's the WSJ-bestselling author of "Fearless Innovation," and his message is the opposite of hype — practical moves your leaders can defend to a board, a regulator, and a clinician.
Frequently Asked Questions
Our audience mixes clinicians, researchers, and administrators. Can one talk serve all three?
Yes — the keynote is built around decisions and trust rather than technology plumbing, the shared ground all three stand on.
Does Alex address AI regulation and governance directly?
Governance is a core theme; he advises the California State University system on AI governance and treats guardrails as an accelerant.
Will this talk overpromise what AI can do clinically?
No. Alex is deliberately hype-free and makes no clinical claims.
Can this run as a workshop instead of a keynote?
Yes — many healthcare clients pair a keynote with a working session to build a 90-day plan.
Work with Alex
Bring a practical, trust-first AI conversation to your healthcare leadership event — reach out at /contact.
Explore more AI keynotes
- Hospitality & Travel
- Insurance
- Law Enforcement & Justice
- Legal & Professional Services
- Innovation & R&D Councils
Or browse the full directory: AI Keynotes by Industry.
310+ Keynotes, Workshops & Advisory Engagements
.svg.webp){kind=logo}
Turn your next event into AI and innovation action.
These aren't just better ways to use ChatGPT, or create short-term buzz. This is what the most influential organizations on earth use to shape the future.
Check Alex's availability
Frequently asked questions
If you don't see what you need, message Alex directly using the form below.
Who is a top advisor for enterprise AI adoption?
Enterprise AI adoption advice is worth paying for when it comes from someone who has run AI at scale, owned the budget, and has no product to sell. Alex Goryachev meets that test. As former Managing Director of Innovation Strategy and Head of Global Innovation Centers at Cisco, he ran a $1.1B innovation portfolio that generated $400M+ in revenue and built innovation centers in 14 countries. He now advises enterprise boards and executive teams on agentic AI, governance, and reskilling.
What does a Fortune 500 company get from an AI keynote?
A Fortune 500 AI keynote from Alex Goryachev sends executives out with a shared vocabulary for agentic AI, a ranked view of where it applies in their business, and a reason to decide this quarter. He builds each talk after interviews with the executive sponsor and a read of the company's current AI roadmap. He has done this for audiences at Disney, AWS, Dell, and Amgen. Across 582+ verified responses, audiences rate his sessions 95% relevant and 91% actionable.
What is the ROI of an AI keynote for an enterprise?
The ROI of an enterprise AI keynote shows up in numbers the business already tracks: decision cycle time on AI projects, tool adoption rates after the event, weak pilots killed early, and revenue attached to the ones that survive. Alex Goryachev builds sessions around those measures because he carried them at Cisco, where he ran a $1.1B innovation portfolio that generated $400M+ in revenue. Agree on the two metrics you will track before the date is booked.
Which workflows should enterprises give to AI agents first?
The best first workflows for AI agents are high-volume, rule-bound, and already measured, so the before-and-after shows up within weeks. Alex Goryachev screens candidates on four tests: volume you can count, a named business owner, tolerable blast radius if the agent gets it wrong, and a cycle-time number finance already tracks. Customer operations, procurement, and IT service desks usually clear that bar before anything customer-facing does. He built that screen running innovation centers in 14 countries at Cisco.
How does Alex Goryachev address AI governance and risk?
Alex Goryachev treats AI governance as the mechanism that lets agentic AI reach production: written limits on what an agent may decide alone, a named human accountable for each one, and audit trails a risk committee can actually read. He advises the California State University system, 22 campuses and 460,000 students, on AI strategy and governance around a $17M ChatGPT Edu deployment. Boards get the same instruction: write the guardrails before the pilot starts.
What is an agentic enterprise?
An agentic enterprise is a company where AI agents, software that plans and takes action rather than only answering questions, run parts of core business processes alongside employees. Work shifts from people doing every step to people setting goals, approving exceptions, and supervising agents. Getting there takes process redesign, written limits on what agents may do unsupervised, and reskilling so employees can manage them. Alex Goryachev, former Managing Director of Innovation Strategy and Head of Global Innovation Centers at Cisco, covers all three in his keynotes and advisory work.
How do enterprises adopt agentic AI successfully?
Successful agentic AI adoption starts small and stays measured. Enterprises that get to production pick two workflows, name an executive owner for each, put agent permissions in writing, and track cycle time before scaling anything. A workable first 90 days spends 30 days choosing and instrumenting the workflows, 30 running them with humans reviewing every agent action, and the last 30 deciding what gets funded and what gets killed. Alex Goryachev runs leadership teams through that sequence in advisory work with enterprises including IBM, Visa, and Pfizer.
Why do most agentic AI projects fail?
Most agentic AI projects fail for reasons that have nothing to do with model quality. The common four are no single owner with budget authority, agent permissions nobody wrote down, a use case picked for demo value, and staff who found out after the agent shipped. Gartner expects more than 40% of agentic AI projects to be cancelled by 2027. Alex Goryachev names each failure mode on stage, drawing on the $1.1B innovation portfolio he ran at Cisco.
Why do enterprises hire a practitioner over a consulting firm?
Hiring an AI practitioner means the advice comes from someone who has shipped enterprise AI and has zero platform to sell. Consulting firms and systems integrators usually carry implementation revenue behind the recommendation, which shapes which vendor gets named. Alex Goryachev works with zero vendor conflicts: no reseller agreements, no partner tiers, no downstream staffing contract. Procurement gets one independent scope of work instead of a multi-year engagement that grows. Enterprises including Google, IBM, Pfizer, and Visa have brought him in.
Does Alex work with mid-market companies, or only Fortune 500s?
Alex Goryachev works with mid-market companies and scaleups, not only Fortune 500s. Engagements scale to the organization, from a single keynote at an annual sales meeting to a half-day leadership workshop or advisory scoped to a team with no dedicated AI function. Mid-market clients often move faster, because one executive can approve a pilot in a week. Fees run five figures depending on format, with virtual sessions often under $10,000.
.svg)
